PubRank

J P Kriss

Author PubWeight™ 61.86‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int 1985 4.76
2 Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex to extraocular muscle membrane. Endocrinology 1974 1.92
3 Appearance of Graves' disease on orbital computed tomography. J Comput Assist Tomogr 1979 1.67
4 Supervoltage orbital radiotherapy for Graves' ophthalmopathy. J Clin Endocrinol Metab 1973 1.66
5 Prognostic factors in the radiotherapy of Graves' ophthalmopathy. Int J Radiat Oncol Biol Phys 1990 1.65
6 Survival time of circulating long-acting thyroid stimulator in neonatal thyrotoxicosis: implications for diagnosis and therapy of the disorder. Pediatrics 1965 1.39
7 Reproducibility of thallium-201 myocardial imaging. Circulation 1977 1.36
8 HL-A antigens as markers for disease susceptibility and autoimmunity in Graves' disease. J Clin Endocrinol Metab 1974 1.33
9 Studies on the pathogenesis of the ophthalmopathy of Graves' disease. J Clin Endocrinol Metab 1967 1.26
10 Radioisotopic thyroidolymphography in patients with Graves' disease. J Clin Endocrinol Metab 1970 1.11
11 Clinical experience with sensitive thyrotropin measurements: diagnostic and therapeutic implications. J Nucl Med 1985 1.08
12 Screening for bone metastases. Are only scans necessary? JAMA 1975 1.06
13 Measurements by competitive binding radioassay of serum anti-microsomal and anti-thyroglobulin antibodies in Graves' disease and other thyroid disorders. J Clin Endocrinol Metab 1971 1.06
14 Studies on the pathogenesis of Graves' ophthalmopathy (with some related observations regarding therapy). Recent Prog Horm Res 1975 1.05
15 Computed tomography in orbital pseudothumor (idiopathic orbital inflammation). Radiology 1976 1.04
16 Review of a 5-year experience with the radiostrontium bone scintiscan. Calif Med 1972 1.02
17 Allogeneic cytolysis of reconstituted membrane vesicles. Proc Natl Acad Sci U S A 1979 0.98
18 Radioisotopic angiocardiography: findings in congenital heart disease. J Nucl Med 1972 0.98
19 Alterations in serum thyrotropin (TSH) and thyroid function following radiotherapy in patients with malignant lymphoma. J Clin Endocrinol Metab 1971 0.97
20 Interpolative background subtraction. J Nucl Med 1976 0.94
21 Distribution and fate of synthetic lipid vesicles in the mouse: a combined radionuclide and spin label study. Proc Natl Acad Sci U S A 1974 0.93
22 The influence of lipid substitution on thyrotropin-receptor interactions in artificial vesicles. Endocrinology 1977 0.91
23 Radioisotopic angiocardiography. Wide scope of applicability in diagnosis and evaluation of therapy in diseases of the heart and great vessels. Circulation 1971 0.91
24 In vivo distribution of vesicles loaded with radiopharmaceuticals: a study of different routes of administration. J Nucl Med 1975 0.91
25 Monoclonal antithyroglobulin antibodies derived from immunizations of mice with human eye muscle and thyroid membranes. J Clin Endocrinol Metab 1986 0.91
26 Graves' ophthalmopathy following external neck irradiation for nonthyroidal neoplastic disease. J Clin Endocrinol Metab 1973 0.90
27 Studies of an in vitro binding reaction between thyroid microsomes and long acting thyroid stimulator globulin (LATS). I. Development of solid-state competitive binding radioassay methods for measurement of antimicrosomal and antithyroglobuin antibodies. J Clin Endocrinol Metab 1970 0.89
28 HL-A antigens in Japanese Patients with Graves' disease. Tissue Antigens 1975 0.89
29 Technetium-99m pyrophosphate myocardial uptake in patients with stable angina pectoris. Am J Cardiol 1977 0.88
30 Computed tomography in Graves' ophthalmopathy. Radiology 1976 0.88
31 Thyroglobulin-independent, cell-mediated cytotoxicity of human eye muscle cells in tissue culture by lymphocytes of a patient with Graves' ophthalmopathy. Life Sci 1983 0.88
32 Unruptured aneurysm of the sinus of valsalva producing right ventricular outflow obstruction. Am J Med 1972 0.88
33 Treatment of orbital pseudotumor (idiopathic orbital inflammation) by radiation therapy. Int J Radiat Oncol Biol Phys 1980 0.87
34 Cell-mediated lysis of lipid vesicles containing eye muscle protein: implications regarding pathogenesis of Graves ophthalmopathy. Proc Natl Acad Sci U S A 1979 0.87
35 Inactivation of long-acting thyroid stimulator (LATS) by anti-kappa and anti-lambda antisera. J Clin Endocrinol Metab 1968 0.85
36 Radiometric measurement of thyroglobulin-antithyroglobulin immune complex in human serum. J Clin Endocrinol Metab 1977 0.85
37 Sounding board: On white coats and other matters. N Engl J Med 1975 0.85
38 The long-acting thyroid stimulator and thyroid disease. Adv Intern Med 1970 0.84
39 The diagnosis of intracardiac metastasis of colon carcinoma by radioisotopic and roentgenographic studies. Am J Cardiol 1970 0.83
40 Immunoradiometric assay for serum thyroglobulin: semiquantitative measurement of thyroglobulin in antithyroglobulin-positive sera. J Clin Endocrinol Metab 1979 0.83
41 Helper and suppressor activities of lymphocyte subsets on antithyroglobulin production in vitro. J Clin Endocrinol Metab 1985 0.82
42 Tc99m labelled toluidine blue O for liver scintillography. Int J Appl Radiat Isot 1968 0.81
43 Purification of human anti-thyroglobulin. J Clin Endocrinol Metab 1975 0.81
44 Preparation of radiolabeled thyroid-stimulating immunoglobulins (TSI) by recombining TSI heavy chains with 125I-labeled light chains: direct evidence that the product binds to the membrane thyrotropin receptor and stimulates adenylate cyclase. Endocrinology 1978 0.80
45 Combined superior vena cava obstruction and pericardial effusion demonstrated by radioisotopic angiocardiography. J Nucl Med 1970 0.80
46 Radiotherapy of lymphoid diseases of the orbit. Int J Radiat Oncol Biol Phys 1985 0.80
47 In vitro stimulation by long-acting thyroid stimulator of thyroid glucose oxidation and 32P incorporation into phospholipids. J Clin Invest 1968 0.79
48 Peripheral blood lymphocytes from normal individuals can be induced to secrete immunoglobulin G antibodies against self-antigen thyroglobulin in vitro. J Clin Endocrinol Metab 1985 0.79
49 Radioisotopic angiocardiography. Preoperative and postoperative evaluation of patients with diseases of the heart and aorta. Radiol Clin North Am 1971 0.79
50 Membrane-binding antibodies in patients with Graves' disease and other autoimmune diseases. J Clin Endocrinol Metab 1982 0.79
51 Distribution and scintiphotography of a new complex, pentavalent technetium-99m citrate: studies in the rodent. J Nucl Med 1967 0.78
52 Vesicle interactions with polyamino acids and antibody: in vitro and in vivo studies. J Nucl Med 1975 0.78
53 A solid phase, sandwich-type radioimmunoassay for antithyroglobulin: elimination of false positive results and semiquantitative measurement of antithyroglobulin in the presence of elevated thyroglobulin. J Clin Endocrinol Metab 1979 0.78
54 Alteration of mammalian cells by interaction with artificial lipid vesicles. Cancer Res 1976 0.77
55 Therapy with occlusive dressings of pretibial myxedema with fluocinolone acetonide. J Clin Endocrinol Metab 1967 0.77
56 New thoughts about the cause and treatment of the severe ocular manifestations of Graves' disease. Scott Med J 1974 0.77
57 The long-acting thyroid stimulator. Calif Med 1968 0.76
58 Gallium-67 citrate scanning in Hodgkin's disease and non-Hodgkin's lymphoma. Cancer 1976 0.76
59 Editorial: Hyperthyroidism. Calif Med 1970 0.75
60 Simple evaluation of thyroid function. West J Med 1988 0.75
61 Treatment of exophthalmos and pretibial myxoedema with plasmapheresis. Br Med J 1979 0.75
62 Radioisotopic angiocardiography: findings in mitral stenosis and mitral insufficiency. J Nucl Med 1970 0.75
63 Scintiphotographic studies of acquired cardiovascular disease. Semin Nucl Med 1973 0.75
64 Degradation of C14-labeled thymidine and its halogenated analogues in man. Adv Tracer Methodol 1966 0.75
65 [Proceedings: Binding of thyroglobulin and thyroglobulin-antithyroglobulin immune complex with the membrane fraction of the extraocular muscle]. Nihon Naibunpi Gakkai Zasshi 1974 0.75
66 An improved assay for thyrotropin-binding blocking activity in serum of patients with Graves' disease. J Endocrinol Invest 1984 0.75
67 The accuracy of 111InCl3 as a bone marrow scanning agent. Radiology 1976 0.75
68 HLA antigens in Japanese patients with Graves' disease and Hashimoto's disease [proceedings]. Diabete Metab 1976 0.75
69 Indium bone marrow scintigraphy as an aid in selecting marrow biopsy sites for the evaluation of marrow elements in patients with lymphoma. Cancer 1976 0.75
70 Biological activity of autoantibodies associated with Graves' dermopathy. J Clin Endocrinol Metab 1989 0.75
71 Variable time-lapse videoscintiscope: a modification of the scintillation camera designed for rapid flow studies. J Nucl Med 1969 0.75
72 Preparation and binding of antimicrosomal antibody-free LATS, and the effect of iodination on LATS biological activity. J Clin Endocrinol Metab 1971 0.75
73 Reliability and reproducibility of interpretation of 99mtechnetium pyrophosphate myocardial scintigrams. Clin Cardiol 1979 0.75
74 Radioisotopic coronary arteriography. Kaku Igaku 1972 0.75
75 Guidelines and criteria for a committee authorizing the use of radioactive isotopes in humans. J Nucl Med 1967 0.75
76 Acute intracardiac volume changes demonstrated with radioisotopic angiocardiography. J Thorac Cardiovasc Surg 1972 0.75
77 Selective, symmetric, skeletal muscle uptake of Tc-99m pyrophosphate in rhabdomyolysis. Clin Nucl Med 1985 0.75
78 Thyrotropin binding and long acting thyroid stimulator absorbing activities in subcellular fractions from isolated thyroid cells and thyroid homogenates. Endocrinology 1977 0.75
79 A method to optimise the use of a grayshade scale in nuclear medicine images. Comput Biomed Res 1976 0.75
80 Congressional Image of NIH. Science 1963 0.75
81 Lipid vesicle interaction with EMT-6 tumor cells and effect on subsequent cell growth. Biochem Biophys Res Commun 1976 0.75
82 Distribution and scintiphotography of a new lung-scanning agent, 99mTc-macroaggregated thionin: studies in the rodent. J Nucl Med 1969 0.75
83 Diagnosis of congenital and acquired cardiovascular diseases by radioisotopic angiocardiography. Trans Assoc Am Physicians 1969 0.75
84 Studies of radiopharmaceutical-enclosing lipid-protein vesicles formed from native plasma components. J Nucl Med 1977 0.75
85 Diagnosis of pericardial effusion by radioisotopic angiocardiography. J Nucl Med 1969 0.75
86 Video instrumentation for radionuclide angiocardiography. Am J Cardiol 1973 0.75
87 Vesicle interactions with antibody and peptide hormone: role of vesicle composition. J Nucl Med 1976 0.75
88 Multiple left ventricular outflow obstructions. Aortic valvular and supravalvular stenosis and coarctation of the aorta. J Thorac Cardiovasc Surg 1972 0.75
89 Albumin-loading effect: a pitfall in saline paper analysis of 99mTc-albumin. J Nucl Med 1974 0.75
90 Technetium-99m(V)-citrate complex for estimation of glomerular filtration rate. Nature 1967 0.75
91 Letter: Orbital radiotherapy for the ophthalmopathy of Graves's disease. N Engl J Med 1974 0.75
92 A study of o-cresolphthalexon and its analogs as cholescintigraphic 111In carriers. Invest Radiol 1978 0.75
93 Robert Reid Newell, 1892-1965. J Nucl Med 1966 0.75
94 Distribution and scintiphotography studies of 99mTc-iron colloid in the rabbit. J Nucl Med 1969 0.75